Unsurprisingly a documented case of a health worker with an aggravated incidence of rosacea due to the continued use of personal protective equipment has been published. For many rosacea sufferers around the world that are required to wear PPE for work purposes this may be a real issue. Indeed in many countries a face mask […]
The publicity around the launch for Zilxi, the new 1.5% topical minocycline based treatment for rosacea contains confirmation that the list price for a 30gm prescription will be $485. Now known as VYNE Therapeutics, the makers of Zilxi are preparing to make their recently FDA approved treatment for the papules and pustules of rosacea available […]
The FDA recently approved a new topical treatment for the papules and pustules of rosacea. This topical treatment contains 1.5% minocycline in a foam emulsion. The main claim to fame of a topical antibiotic is that it can deliver a higher dose of the active ingredient to the layers of skin, than taking a tablet. […]
This paper published in the Journal of Cosmetic Dermatology details a clinical trial to prove that 3 products from LETI Pharma are able to reduce the redness of rosacea. The study was supported by LETI and trailed the use of their micellar water, cream and serum. Trial participants were blinded and not informed about the […]
A pre-proof version of an article to appear in the Journal of the American Academy of Dermatology details a small double blind study that found that oral hydroxychloroquine 200mg twice a day offered similar benefits to rosacea sufferers compared to doxycycline 100mg a day. Hydroxycholorquine (HCQ) is marketed under the name Plaquenil and is best […]
